HPV vaccine recommended, despite debate
By Hannah Catchings
Sexually active women, listen up.
According to the Centers for Disease Control and Prevention, half of all sexually active people will pick up HPV, the principle virus behind cervical cancer - and that's just the minimum. The good news is that few women will actually get cervical cancer, an easily preventable disease.
Regular screenings and follow-ups have been the long-time safeguards against this gynecological cancer; however, in 2006 pharmaceutical company Merck released a promising new cervical cancer vaccine known as Gardasil.
"This vaccine prevents four viruses that account for about 70 percent of cervical cancers," said Virology Professor Dr. Konstantin Kousoulas. "The vaccine is composed of a single protein made by four different papillomaviruses. This is why it is called Human Papillomavirus Quadrivalent (types 6, 11, 16, and 18) Vaccine."
With over 25 million doses of Gardasil distributed throughout the US, the vaccine has enjoyed a popular, yet controversial history. As vaccine risks become an increasingly topical issue, Gardasil's contentious track record heightens concerns associated with "the jab."
For starters, there is the vaccine's approved age range of females from 9 to 26, with the CDC recommending routine vaccination for girls between 11 and 12. Vaccinating young girls for a disease spread by sexual contact might seem senseless, but Dr. Kousoulas explained that the vaccine won't work if a person has already contracted any of the dangerous HPV virus strains.
"The vaccine is a preventative vaccine," said Dr. Kousoulas. "Therefore, it is imperative to vaccinate young women and girls prior to the onset of sexual activity."
After the release of a new government report in August, safety concerns are another big issue surrounding the cervical cancer vaccine. The report basically questions many of the side effects associated with the vaccine, finding higher occurrences of fainting and blood clots as well as citing 32 unconfirmed deaths.
Other side effects range from fever and nausea to vomiting and dizziness, including more serious but rare complications like paralysis.
"So far the rate of adverse reactions, minor and major, is less than 1 in 5,000 women," said Dr. Kousoulas. "None of the serious conditions have been proven to be directly caused by the vaccine."
Although these adverse reactions make a much better story, it is important to keep in mind the millions of women who had no reaction at all. Communication studies senior Rachelle' David got the vaccine her freshman year.
"My sister-in-law bugged me until I got it because she is the head nurse of a hospital and wanted me to protect myself," said David. "I'm glad I got the vaccine. It was quick, easy and prevents me for the future."
The vaccination and more information and counseling regarding the vaccination are available at the LSU Student Health Center. To learn more talk to your doctor, visit the Student Health Center, or go to www.cdc.gov.
Originally Published: Issue 819 - October 14, 2009
| Share on Facebook |



